Correlation Between Korean Drug and FNSTech

Can any of the company-specific risk be diversified away by investing in both Korean Drug and FNSTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Korean Drug and FNSTech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Korean Drug Co and FNSTech Co, you can compare the effects of market volatilities on Korean Drug and FNSTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Korean Drug with a short position of FNSTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Korean Drug and FNSTech.

Diversification Opportunities for Korean Drug and FNSTech

0.57

Correlation Coefficient

Korean Drug  FNSTech

Very weak diversification

The 3 months correlation between Korean and FNSTech is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Korean Drug Co and FNSTech Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FNSTech and Korean Drug is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Korean Drug Co are associated (or correlated) with FNSTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FNSTech has no effect on the direction of Korean Drug i.e., Korean Drug and FNSTech go up and down completely randomly.

Pair Corralation between Korean Drug and FNSTech

Assuming the 90 days trading horizon Korean Drug is expected to generate 20.24 times less return on investment than FNSTech. But when comparing it to its historical volatility, Korean Drug Co is 2.56 times less risky than FNSTech. It trades about 0.02 of its potential returns per unit of risk. FNSTech Co is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  777,000  in FNSTech Co on December 26, 2024 and sell it today you would earn a total of  246,000  from holding FNSTech Co or generate 31.66% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Korean Drug Co  vs.  FNSTech Co

Korean Drug

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Korean Drug Co are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Korean Drug is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

FNSTech

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in FNSTech Co are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, FNSTech sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Korean Drug and FNSTech

The main advantage of trading using opposite Korean Drug and FNSTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Korean Drug position performs unexpectedly, FNSTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FNSTech will offset losses from the drop in FNSTech's long position.

The idea behind Korean Drug Co and FNSTech Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.